<DOC>
	<DOC>NCT01066676</DOC>
	<brief_summary>Medical condition under investigation: Osteoarthritis of the hip or knee Number of patients planned: 480 adult patients Main objective: To evaluate and compare the tolerability profile of Dexibuprofen Gebro 400 mg powder for oral suspension compared to Ibuprofen 400 mg in patients with painful osteoarthritis of the hip or knee Secondary objectives: To compare the overall efficacy of Dexibuprofen Gebro 400 mg powder for oral suspension compared to Ibuprofen 400 mg in patients suffering from different complaints due to painful osteoarthritis of the hip or knee</brief_summary>
	<brief_title>Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Hip</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>male or female patients aged between 18 and 75 years everyday joint pain for the past three months global pain intensity in the involved joint (hip or knee) of "moderate" to "severe" within the last 48 h acute inflammation or ischaemic necrosis paget's disease, chondrocalcinosis, ochronosis of the hip/knee joint slowly progressing hip/knee arthropathy in particular of tuberculosis aetiology hip/knee arthropathy due to diabetes mellitus Charcot's joint villous synovitis chondromatosis of the synovium patients with existing gastritis or existing ulcers or bleedings in the gastrointestinal tract or patients with history of gastrointestinal ulcers or gastrointestinal haemorrhage in the past 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>